Contineum Therapeutics, Inc.
CTNM • NASDAQ
Contineum Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Carmine N. Stengone, with a market cap of $498.1M.
CEOCarmine N. Stengone
Next Earnings
Upcoming earnings announcement for Contineum Therapeutics, Inc.
Date
Wednesday, May 13, 2026 (in a month)
Timing
Before Market Open (3:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.54
Earnings History
Past 8 earnings reports for Contineum Therapeutics, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 5, 2026 | Q4 2025 | -$0.49Est: -$0.43 | -14.0% | -Est: $5.0M | -100.0% |  10-K |
| Oct 30, 2025 | Q3 2025 | -$0.45Est: -$0.51 | +11.8% | -Est: $5.0M | -100.0% | 10-Q |
| Aug 5, 2025 | Q2 2025 | -$0.62Est: -$0.47 | -31.9% | -Est: $6.0M | -100.0% | 10-Q |
| May 14, 2025 | Q1 2025 | -$0.62Est: -$0.57 | -8.8% | - | — | 10-Q |
| Mar 6, 2025 | Q4 2024 | -$0.56Est: -$0.44 | -27.3% | - | — | 10-K |
| Nov 6, 2024 | Q3 2024 | -$0.40Est: -$0.43 | +7.0% | - | — | 10-Q |
| Aug 13, 2024 | Q2 2024 | -$0.39Est: -$0.35 | -11.4% | - | — | 10-Q |
| May 16, 2024 | Q1 2024 | -$3.55 | — | - | — | 10-Q |